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Photodynamic Therapy for Superficial Esophageal Cancer
Using an Excimer Dye Laser
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In order to improve the therapeutic effectiveness ofphotodynamic therapy with Photofrin II and laser
light for superficial esophageal cancer, we employed an excimer dye laser instead of an argon dye
laser. Eight superficial esophageal cancer lesions (7 cases) were treated. Of these 8 lesions, 6 were
cured by initial treatment, while one lesion required another treatment. The final rate of cure was
88% (7/8).
KEY WORDS: endoscopic treatment, excimer dye laser (EDL), hematoporphyrin derivative
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INTRODUCTION
Photodynamic therapy (PDT) is anew method to treat ma-
lignant tumors using hematoporphyrin derivative (HpD)
as the photosensitizer and a laser as the excitation light
source. It also can be employed endoscopically
(Dougherty et al., 1979; Hayata et al., 1982). This method
kills malignant cells through a photochemical reaction,
rather than through heat. Because HpD has a higher affin-
ity for malignant tissue than for normal tissue, after in-
travenous injection it is concentrated more and retained
longer in malignant tissue than in normal tissue (Lipson
and Baldes, 1960). Stimulation by low-power laser light
to irradiate the tumorous lesion and surrounding area
causes release of singlet oxygen from HpD, and malig-
nant tissue can be destroyed selectively (Okuda et al.,
1984; Weishaupt et aL, 1976). Tumor ischemic necrosis
as a result of microvascular occlusion is also involved in
the tumorcidal process (Star et al., 1986).
From 1981 to 1990, we have treated seven superficial
esophageal cancer lesions (six cases) by PDT with an
argon dye laser (ADL, models 171-08 and 375-03,
Spectra-Physics, Mountain View, Calif., US). The results
showed thatPDT is very effective for all morphologic su-
perficia esophageal cancerexcept for the protruding type.
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However, analyzing results according to the depth ofcan-
cer invasion in these seven lesions, the rate ofcure for sub-
mucosal carcinomas was only 33% (1/3), whereas that of
mucosal carcinomas was 100% (4/4) as shown in Table
(Mimura, Ichii and Okuda, 1991). These data can be in-
terpreted to indicate that the ADL laser beam could not
penetrate and supply sufficient energy to activate HpD in
the submucosal layer.
In 1990, therefore, we investigated an excimerdye laser
(EDL, Hamamatsu Photonics, Hamamatsu, Japan) as an
excitation light source for PDT, because its low-power
pulsed beam was expected to be more efficient at excit-
ing HpD than continuous wave lasers such as ADL and
high frequency pulsed lasers such as copper vapor dye
laser (CuVDL). In animal tumors it was proved that EDL
is superior to ADL in teams of photodynamic action
(Okunaka et al., 1992).
In this article, we first present our clinical data on PDT
for the treatment ofsuperficial esophageal cancer and pre-
sent a representative case. Other endoscopic methods are
also discussed, including a comparison ofEDL and other
laser equipment.
MATERIALS
Eight superficial esophageal cancer lesions (seven cases)
were treatedbyPDT with EDL. Surgery was not indicated
because of high risk factors or old age. There were six
men and one woman, ranging in age from 52 to 74 (mean,
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Table I Rates of cure obtained by PDT with the ADL in superficial
esophageal cancers, classified by depth
Depth of Number of Number ofcured
invasion cases cases (%)
Mucosa 4 4 (100%)
Submucosa 3 (33%)
Total 7 5 (71%)
67) years. In all cases a histologic diagnosis of squamous
cell carcinoma was obtained by biopsy, and the depth of
cancer invasion was assessed by endoscopic findings and
endoscopic ultrasonography. The follow-up periods
ranged from 12 to 44 months.
METHODS
The PDT procedure includes three important points, that
is, administration of photosensitizers, laser light irradia-
tion, and pre- and postprocedural management (Table 2).
Administration of Photosensitizer
Two mg/kg of PHE (freeze-dried Photofrin II) was in-
jected intravenously. The solution was made by dissolv-
ing 75 mg/v ofPHE with 30 mL of5% glucose solution.
The photosensitizers used in our institute were hemato-
porphyrin derivative (HpD, Photofrin I) and dihemato-
porphyrin ether/ester (DHE, Photofrin II). HpD is a
complex mixture derived from porphyrin, whereas DHE
is a mixture of the dihematoporphyrin ether and dihe-
matoporphyrin ester purified from HpD. For initial stud-
ies, HpD was provided from Dr. T. J. Dougherty of
Roswell Park Memorial Institute, Buffalo, New York,
through Dr. Y. Hayata of Tokyo Medical College, for a
project on Cancer Research funded by the Ministry of
Health and Welfare, Japan. In later studies, HpD was ob-
tained from Photofrin Medical Inc., Cheektowaga, N. J.,
and from The Queen Elizabeth Hospital, Woodville, S.
Aust. 5011, Australia, and DHE was obtained from
Photofrin Medical Inc., Raritan, N. J. From 1989 to 1990,
a phase II study ofPDT was performed in Japan, andDHE
(manufactured for Quadra Logic Technologies,
Vancouver, Canada, by Ortho Diagnostic Systems, Inc.,
Raritan, N. J.) was providedby Lederle, Japan. From 1990
Table 2 PDT procedure
1. Intravenous injection of 3 mg/kg ofHpD
or 2 mg/kg of PHE.
2. Approximately 50 hours later, the entire lesion plus a 5-mm
width of marginal mucosa is irradiated with a laser beam
at 630 nm wavelength transmitted endoscopically.
Standard dose: 90 J/cm with ADL, 60 J/cm with EDL.
3. Patients are protected from hypersensitivity to light
and are treated for the subsequently formed ulcer.
to 1992, a phase III study was performed and completed
in Japan (Kato et al., 1993), and at present PHE is pro-
vided by Lederle, Japan, for compassionate use.
Laser Light Irradiation
About 50 hours after intravenous injection, the entire le-
sion plus a 5-mm wide perimeter of mucosa was irradi-
ated with anEDLbeam at630nm wavelength transmitted
endoscopically. The laser beam was condensed and led to
a 400-pm single quartz fiber (Obara Kogaku, Tokyo,
Japan) with a divergence of 20 at the simply cut fiber tip
without lens or diffuser. This quartz fiber was encased in
a Teflon tube of 2.0mm in outside diameter to be able to
pass through the working channel of the conventional
fiberscope, and air was pumped at a rate of 50 to 100
mL/min into the free space between the fiber and the tube
to protect the tip of the quartz fiber from contamination.
Excimer Dye Laser
The ultraviolet laserbeam of308 nm wavelength, which is
delivered from the XeC1 excimer laser, pumps the dye laser
with Rhodamine 640, which then can induce to emit a sec-
ondary laser beam of 630 nm wavelength by adjusting the
concentration of the dye to 0.4 mM. The EDL (model PDT
EDL- 1, Hamamatsu Photonics, Hamamatsu, Japan) has the
following characteristics: wavelength, 630 nm; pulse en-
ergy, 8 rnJ; peak power, 800kW; pulse width, 10 nsec; fre-
quency ofrepetition, 20, 30, or40 Hz (Hirano et al., 1990).
Filters Used in PDT
InPDT, an electronic endoscope is not applicable, because
excessive amounts of red light at 630 nm wavelength for
irradiation prevent the CCD chip from forming an image.
A green filter shouldbe placedon the eyepiece ofthe fiber-
scope to protect the naked eye from being dazzled during
photoradiation. We used an acetate filter (model SP-15,
Fuji Filter, Tokyo, Japan) for observation and photogra-
phy. It is a green filter for sensitivity tests of X-ray film,
with a peak transmission of 63% at 530 nm wavelength.
The transmissivity rate at 630 nm is 2%. We also inserted
a green filter (model SP-19) in front of the CCD camera
in a fiberscope-TV system (model OTV-F2, Olympus,
Tokyo, Japan). It is one of the filters for separating three
primaries with a peak transmissivity of 75% at 520 nm
and 17% at 630 nm (Fuji Film, 1993).
Energy Intensity of Irradiation
The irradiation was delivered at a total dose of more than
60J/cm2. Forwider lesions, the irradiation spotofaboutone
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livering the scheduled dose of light there, the field of irra-
diation was shifted to the remaining part so as to irradiate
the entire region as uniformly as possible. The effective ir-
radiation of all parts of the lesion was confirmed by ob-
servingmucosalchangeunderdirectvisionatapauseduring
the irradiation. Uniform irradiation was difficult, especially
with large lesions,becauseofesophageal peristalsis andres-
piratory movement. However, assuming uniform irradia-
tion, the total energy density (J/cm2) of the irradiated area
was calculated by the following formulas for the ADL or
EDL, respectively (Mimura, Ichii and Okuda, 1993).
In the continuous wave laser:
output(W) x time(sec)
total irradiated area (cm2)
our experience in the treatment of superficial esophageal
cancer. As PDT w.as indicated only for relatively early-
stage cases, it always can reduce the cancerous tissue al-
most completely, even if it did not give a complete cure.
On the other hand, ifPDT failed to eradicate even a small
portion ofthecancerous lesion, the treatmentwas rendered
useless. Therefore, a grade of partial response was classi-
fied as no cure in our evaluation (Mimura et al., 1990).
RESULTS
Of these eight superficial esophageal cancers, six were
cured by initial PDT, whereas one lesion required another
PDT to obtain a complete cure. The final rate ofcure was
88% (7/8) as shown on Table 3.
In the pulsed laser:
SIDE EFFECTS
pulse energy(J/pulse) x frequency(pulse/sec) x time(sec)
total irradiated area (cm
Pre- and Post-therapeutic Care
Soon after injection of PHE, the patients were placed in a
dark room not only to protect them from photosensitivity
disease but also to prevent the photosensitizer from losing
its biologic effect. After PDT, the patients were kept in bed
withoutoral feedingandweregivencontinuous intravenous
glucose and saline with an H2-blocker and antibiotics for
two days to allow healing ofulcers. During this period, the
patients were kept in dim light, and their faces and hands
were coated with antisunburn cream. These restrictions
were gradually reduced, and the patients returned to nor-
mal conditions after week (Mimura and Okuda, 1993).
Evaluation of Response
The response was evaluatedbyendoscopy with biopsy and
cytology in follow-up examinations. When the ulcer
caused by treatment entered the healing stage 4 weeks
later, the patient was discharged. They were followed up
by endoscopy 2, 3, and 6 months later, then every 6 months
for 2 years, and thereafter once a year. To detect metasta-
sis to the lungs, liver, and mediastinal lymph nodes, the
patients were also followed up by chest X-ray, ultrasonic
echography, and computed tomography. The curativity
was graded two categories: cure or no cure. Although it is
impossible to prove the cancer was cured by clinical ex-
aminations,wegaveadefinitionofcure in this articlewhen
neither local sign ofrecurrence nor metastasis was proved
by follow up examinations in one year. This was based on
Themain toxic effectswere photosensitivityandcutaneous
reaction, seen in one 14.3%) ofseven patients. They lasted
several weeks. In laboratory tests, transient elevations of
GOT and GPT were observed in another patient (14.3%,
1/7). They occurred in the secondPDT and lasted 2 weeks.
No other serious adverse reactions were seen.
CASE
A 73-year-old woman with superficial esophageal cancer
was treated by PDT with PHE and EDL. She could not
undergo surgery, because of heart failure. The clinical
course of PDT is shown by the endoscopic photographs
in Figures 1-6. Endoscopically, the findingwas suspicious
for submucosal invasion and squamous cell carcinoma
was diagnosed by biopsy. Figure shows the finding be-
fore treatment, Figure 2 shows the finding after staining
by iodine. The lesion was located in the middle part of the
esophagus and spread over7 cm2. Figure 3 shows the find-
ing immediately after the irradiation (60 J/cm2) with the
EDL, showing edematous swelling. One week later, a
large, shallow ulcer developed, as shown in Figure 4. Four
weeks later the ulcer healed as shown in Figure 5. Some
Table 3 Rates of cure obtained by PDT with the EDL in superficial
esophageal cancers, classified by depth
Depth of Number of Number ofcured
invasion cases cases (%)
Mucosa 4 4 (100%)
Submucosa 4 3 (75%)
Total 8 7 (88%)102 S. MIMURA, T. OTANI AND S. OKUDA
Figure 1 Before PDT treatment.
minute nodules can be seen in the region of the scar; how-
ever, biopsy revealed no evidence of malignancy. Figure
6 shows the iodine stain finding 6 months later. Two small
unstained spots can be seen in the scar lesion, but both
were negative for malignancy histopathologically.
Follow-up for 3 years after PDT demonstrated no recur-
rence of cancer.
DISCUSSION
Other Endoscopic Curative Treatments
To evaluate the role of PDT in the treatment of superfi-
cial esophageal cancer, other useful endoscopic curative
methods should be taken into consideration. These meth-
ods can be divided into two types: local resection and local
destruction. The former is intended to remove the lesion
for histopathologic evaluation. A high frequency electric
current is used to resect the lesion without causing bleed-
ing. The indications ofthis method, initially developed by
Momma and Makuuchi, were expanded by Inoue et al.,
(1992). This method yields pathologic information such
as depth of cancer invasion, histologic type, presence of
lymph vessel invasion, and presence or absence of cancer
at the margin of the specimen, and therefore can permit
more exact analysis of prognosis in terms of curability
and facilitate decisions concerning further surgical resec-
tion. However, applications of this method are limited by
the nature of the cancerous lesion: that is, its size, depth
of invasion, morphologic type, histologic type, and loca-
Figure 2 After staining with iodine. The 7cm lesion was located in
the mid-thoracic esophagus and was endoscopically suspicious for
submucosal invasion. Biopsy revealed squamous cell carcinoma.
tion. In general, the method is suitable for relatively small
mucosal carcinomas.
Various techniques have been developed for the second
type of treatment, local destruction, including microwave
coagulation and Nd:YAG laser irradiation. Wider and
deeper lesions can be destroyed using these techniques,
butexcessive treatment to obtain complete cure may cause
perforation of the esophageal wall.
Figure 3 Immediately after 60 J/cm PDT with the EDL showing
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Figure 4 One week later, a large, shallow ulcer had formed.
PDT is yet another approach to the local destruction of
malignant tissue. Much progress in PDT was made dur-
ing the first half of the 1980s, and good results have been
reported on its use for the treatment of superficial
esophageal cancers, especially depressed types, without
any report of perforation (Okushima, 1987).
Figure 5 Four weeks later, the ulcer had healed and some minute
nodules could be seen in the region of the scar. However, biopsy showed
no evidence of cancer.
Figure 6 Shows the iodine-stained feature at 6 months after PDT by
electronic endoscope. Two small, unstained spots in the scar were both
negative for malignancy by biopsy. This case has been followed up for
3 years after PDT and has shown no sign of recurrence.
Resection first should be considered to resect the entire
lesion as much as possible, and PDT should be considered
as the treatment of choice only for unresectable lesions.
Side-Viewing Fiberscope
In PDT for gastric cancer, we used a side-view fiberscope
(model GF-20, Olympus, Tokyo, Japan) to irradiate the le-
sion at an angle of 90, keeping a certain distance between
the fiber tip and the lesion since the first trial in 1981.
However, inPDT for esophageal cancer, we used front-view
fiberscope(modelGIF-P10,GIF-XQ20) according tothe tra-
ditional method of diagnostic endoscopy until 1991. Since
the first trial using a side-view fiberscope in PDT for
esophageal cancer in 1992 (Mimura and Imanishi, 1993), we
have used a side-view fiberscope, model GF-20, in PDT for
three cases with esophageal cancer, not only in PDT, but also
in pretreatment examinations and follow-up examinations.
In this procedure, patients with a lesion located on the fight
side can lie in a left lateral position as usual, whereas patients
with a lesion located in the left side, especially from 7 to 10
o’clock, must lie in a fight lateral position. This enabled pho-
toradiation of esophageal cancer from a 90 angle without
any difficulty.
Dose and Response
The relationship between response (cure or no cure) and
irradiated energy intensity (dose: J/cm2) was evaluated in104 S. MIMURA, T. OTANI AND S. OKUDA
terms of depth of cancer invasion and kind of laser used
in PDT in Figure 7 to determine how much energy was
required foracomplete cure in superficial esophageal can-
cer and to compare the efficacy of the ADL and EDL.
In 1981 whenwe startedusingPDT foresophageal can-
cer, little information was available on how much energy
was required for a complete cure. Therefore, based on a
report (Tomson et al., 1974) on laser photoradiation treat-
ment of animal tumors, we used a total dose of204 J/cm2
with the ADL in our first case of superficial esophageal
cancer. Although, such high-energy densities did not
cause any side effects such as perforation or acute medi-
astinitis, it became clearer by our later investigations that
although a high dose did not necessarily improve the re-
sponse, uniform irradiation of the entire lesion including
a marginal zone of intact mucosa was essential. Our data
in Figure 7 show that 90 J/cm2 with the ADL is sufficient
for treatment ofmucosal esophageal cancer. However, the
ADL laser beam could not sufficiently penetrate the sub-
mucosal layer. With EDL, 60 J/cm2 is sufficient not only
for mucosal cancer but also for submucosal cancer. In the
one case in which we could not obtain a complete cure
with the EDL, a small shallow cancer nest was left behind
in the mucosa because of insufficient extent of the irradi-
ation area. Overall, the above data suggest that the EDL
is more efficient in photodynamic action than is the ADL.
Comparison ofADL, CuVDL, and EDL
It has notbeen clearly proved that there are any differences
in physiologic transmissivity between continuous laser
light and pulsed laser light. However, our data show that
biologic effects in PDT varied depending on the charac-
teristics of the laser light. Between 1981 and 1990, the
ADL was used in our institute. In 1988, we tried aCuVDL
(Niic, Kawasaki, Japan) in PDT, anticipating special ef-
fects.Whenwe treated several earlygastric cancersbyPDT
with the CuVDL, subsequent hemorrhagic necrosis on the
lesionfightafterirradiationwasfoundmore obviouslythan
after PDT with the ADL. However, complete cure could
not be obtained in the gastric cancers with submucosal in-
vasion (Ichii et al., 1988). Thereafter, we discontinued its
use, because we could not find any advantages of the
CuVDL in clinical use in early gastric cancer.
We first used the EDL for PDT, in 1990, at 4 rnJ per
pulse, 400 kW of peak power, and 40 pulses per second
Dose and curability in photodynamic therapy ( PDT )
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Figure 7 The relationship between response (cure or no cure) and photoradiated energy intensity (dose: J/cm2) in terms of depth of cancer invasion
and kind of laser used in PDT. Arrows indicate the same case undergoing a second PDT.PHOTODYNAMIC THERAPY FOR SUPERFICIAL ESOPHAGEAL CANCER 105
Table 4 Laser characteristics
Type of Pulse
laser energy
Argon
dye
laser
Copper
vapor
dye laser
Peak Pulse Pulse Average
power width frequency output
(300 mW) 300mW
0.055 mJ 2.5 kW 22 nsec 5,500 Hz 300mW
400 kW 10 nsec 40 Hz 160 mW Excimer 4rnJ
dye laser
for the allowable maximum, to protect the 400-1am single
quartz fiber from destruction (Mimura and Okuda, 1991).
These characteristics of the three kinds of laser are shown
in Table 4. With the EDL, the efficacy of PDT improved
not only for esophageal cancer but also for gastric cancer.
It is difficult to determine the most important individual
factor determining the biologic effect of a pulsed laser in
PDT, but our studies suggest that the most important fac-
tor is peak power. We postulate that pulsed laser light has
several functions, not only of activation ofHpD and heat,
but also an unknown effect. It may be the effect ofa shock
wave (Mimura et al., 1992).
CONCLUSION
PDT with PHE and the EDL is a safe and promising al-
ternative for the treatment of patients with superficial
esophageal cancer who are poor risks for surgery and in
whom mucosal resection is difficult.
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